Rapid worsening of IgM anti-MAG demyelinating polyneuropathy during rituximab treatment

被引:16
|
作者
Stork, Abraham C. J. [1 ]
Notermans, Nicolette C. [1 ]
Vrancken, Alexander F. J. E. [1 ]
Cornblath, David R. [2 ]
van der Pol, W-Luso [1 ]
机构
[1] Univ Med Ctr, Dept Neurol, Rudolf Magnus Inst Neurosci, NL-3584 CX Utrecht, Netherlands
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
关键词
PLACEBO-CONTROLLED TRIAL; NEUROPATHY;
D O I
10.1111/jns5.12018
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:189 / 191
页数:3
相关论文
共 50 条
  • [41] Chronic demyelinating polyneuropathy associated with IgM monoclonal gammopathy without Anti-MAG antibodies: Clinical, electrophysiological and laboratory findings in 18 cases
    Leger, Jean-Marc
    Vargas, Steven
    Neil, Jean
    Fournier, Emmanuel
    Viala, Karine
    Maisonobe, Thierry
    Bouche, Pierre
    Vallat, Jean-Michel
    NEUROLOGY, 2008, 70 (11) : A365 - A366
  • [42] Rituximab therapy in relapsed/refractory IgM related peripheral neuropathies anti-MAG positive
    Carpo, M.
    Zilioli, V
    Fruguglietti, E.
    Olivero, B.
    Cogiamanian, F.
    Goldaniga, M.
    Saccomanno, D.
    Baldini, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 145 - 145
  • [43] Monoclonal IgM and neuropathy: not always anti-MAG
    Jaccard, Arnaud
    BLOOD, 2020, 136 (21) : 2366 - 2367
  • [44] ANTI-MAG IGM PARAPROTEINS FROM SOME PATIENTS WITH POLYNEUROPATHY ASSOCIATED WITH IGM PARAPROTEINEMIA ALSO REACT WITH SULFATIDE
    ILYAS, AA
    COOK, SD
    DALAKAS, MC
    MITHEN, FA
    JOURNAL OF NEUROIMMUNOLOGY, 1992, 37 (1-2) : 85 - 92
  • [45] A RANDOMIZED CONTROLLED TRIAL OF RITUXIMAB IN DEMYELINATING NEUROPATHY ASSOCIATED WITH ANTI-MAG IGM GAMMOPATHY (RIMAG STUDY): STUDY DESIGN AND PROGRESS REPORT
    Bombelli, F.
    Bessirard, V
    Viala, K.
    Leger, J-M
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2009, 14 : 19 - 19
  • [46] RITUXIMAB INDUCED WORSENING OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
    Factora, Tricia
    Chaudhry, Vinay
    MUSCLE & NERVE, 2024, 70 (03) : 526 - 526
  • [47] Efficacy of rituximab in Anti-MAG neuropathy.
    Singh, Jaswinder
    Malani, Ashok
    Festoff, Barry
    Kambhampati, Suman
    BLOOD, 2006, 108 (11) : 370B - 371B
  • [48] The clinical response of rituximab in patients with Anti-MAG antibody-demyelinating polyneuropathy (A-MAG-DP) is associated with alteration of lymphocyte homing and induction of regulatory T cells
    Raju, Raghavan
    Shi, Wei
    Dalakas, Marinos
    ANNALS OF NEUROLOGY, 2006, 60 : S95 - S95
  • [49] B-cell-activating factor in rituximab-treated patients with anti-MAG polyneuropathy
    Benedetti, Luana
    Zardini, Elisabetta
    Briani, Chiara
    Beronio, Alessandro
    Gastaldi, Stefania
    Jarius, Sven
    Mancardi, Gian Luigi
    Schenone, Angelo
    Franciotta, Diego
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (11): : 1291 - 1294
  • [50] TREATMENT OF PATIENTS WITH NEUROPATHY AND ANTI-MAG IGM M-PROTEINS
    NOBILEORAZIO, E
    BALDINI, L
    BARBIERI, S
    MARMIROLI, P
    SPAGNOL, G
    FRANCOMANO, E
    SCARLATO, G
    ANNALS OF NEUROLOGY, 1988, 24 (01) : 93 - 97